ACR24 JAK_TYK Topic Panel
Rheumnow Podcast
00:00
Intro
This chapter features a panel discussion on key findings from ACR 2024 regarding Upadacitinib, a Janus kinase inhibitor, and its effectiveness in treating giant cell arteritis. The conversation includes insights from a randomized controlled trial that showcases improved remission rates and highlights the importance of safety in new treatment approaches.
Transcript
Play full episode
